Digital Pathology Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Digital Pathology Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032



Growth Factors of Digital Pathology Market


The digital pathology market size was valued at USD 1.02 billion in 2023, and the market is now projected to grow from USD 1.15 billion in 2024 to USD 3.86 billion by 2032, exhibiting a CAGR of 16.4% during the forecast period of 2024-2032.

The COVID-19 widespread accelerated the market growth due to a significant rise within the digitization of pathological frameworks. The market's development was moreover ascribed to the critical spike within the adoption of these digital devices, favorable directions for emergency use cases, and decrease in in-person visits to pathologists and doctors.

Higher incidence of chronic infections and ensuing increment within the number of tests are assessed to bolster the product adoption. Increasing product adoption, alongside rising efforts of market players to cater to the developing need for diagnostics, is anticipated to drive the development of the market.

Increasing adoption of Artificial Intelligence-based advanced devices by key customers owing to a higher demand for workflow administration could be a key drift within the worldwide market. The rising center of major companies included in licensing innovative technology on advertising a customized stage for key partners gives them with a competitive advantage and boost in the digital pathology market growth.

Comprehensive Analysis Of digital pathology Market

The digital pathology market and healthcare industry is rising at an exponential rate due to its market division. This market extension successfully gives a point-by-point regional assessments considering the overwhelming supply and demand forces that impact the digital pathology industry. Based on the product, the market is segmented into hardware, software, and storage systems. Based on application, the market is sectioned into disease diagnosis, drug discovery, and others. Based on end-user, the worldwide market is fragmented into hospitals & clinics, clinical laboratories, and others.

North America digital pathology market share keeps escalating at USD 0.37 billion within the worldwide market in 2023. The growing incidence of chronic diseases, such as cardio-diabetic disorders and rising geriatric population, which is at a higher risk of creating such disorders, are anticipated to extend the demand for pathology tests.

The top operating players in the market play a vital role in the growth of the healthcare industry assuring industrial prospectus potentials and setting market standards. These players and their headquarters are: Thermo Fisher Scientific Inc. (U.S.), Hoffmann-La Roche Ltd. (Switzerland), Hamamatsu Photonics K.K. (Japan), 3DHISTECH Ltd. (Hungary), Koninklijke Philips N.V. (Netherland), Apollo Enterprise Imaging Corp (U.S.), Sectra AB (Sweden), Huron Technologies International Inc. (Canada).

In October 2023 F. Hoffmann-La Roche Ltd declared a association with Ibex and Amazon Web Administrations to upgrade the selection of AI-enabled computerized pathology arrangements. This AI-enabled arrangement makes a difference within the conclusion of breast and prostate cancer.

Segmentation Table

Attribute Details

Study Period 2019-2032

Base Year 2023

Estimated Year 2024

Forecast Period 2024-2032

Historical Period 2019-2022

Growth Rate CAGR of 16.4% from 2024-2032

Unit Value (USD billion)

Segmentation By Product

Hardware

-Scanners

-Tissue Microarrayer

-Others

Software

-Pathology Management

-Digital Microscopy Viewers

-Image Analyzers

-Others

Storage Systems

By Application

Disease Diagnosis

Drug Discovery

Others

By End-user

Hospitals & Clinics

Clinical Laboratories

Others

By Geography

North America (By Product, Application, End-user, and Country)

-U.S.

-Canada

Europe (By Product, Application, End-user, and Country/Sub-Region)

-U.K.

-Germany

-France

-Italy

-Spain

-Scandinavia

-Rest of Europe

Asia Pacific (By Product, Application, End-user, and Country/Sub-Region)

-China

-India

-Japan

-Australia

-Southeast Asia

-Rest of Asia Pacific

Latin America (By Product, Application, End-user, and Country/Sub-Region)

-Brazil

-Mexico

-Rest of Latin America

Middle East & Africa (By Product, Application, End-user, and Country/Sub-Region)

-GCC

-South Africa

Rest of Middle East & Africa


1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Trends
4. Key Insights
4.1. Key Industry Developments- Mergers, Acquisitions and Partnerships
4.2. Technological Advancements in Digital Pathology
4.3. Snapshot: Global Digital Health Market, 2022/ 2023
4.4. Impact of COVID-19 on the Market
5. Global Digital Pathology Market Analysis, Insights and Forecast, 2019-2032
5.1. Market Analysis, Insights and Forecast – By Product
5.1.1. Hardware
5.1.1.1. Scanners
5.1.1.2. Tissue Microarrayer
5.1.1.3. Others
5.1.2. Software
5.1.2.1. Pathology Management
5.1.2.2. Digital Microscopy Viewers
5.1.2.3. Image Analyzers
5.1.2.4. Others
5.1.3. Storage Systems
5.2. Market Analysis, Insights and Forecast – By Application
5.2.1. Disease Diagnosis
5.2.2. Drug Discovery
5.2.3. Others
5.3. Market Analysis, Insights and Forecast – By End User
5.3.1. Hospitals & Clinics
5.3.2. Clinical Laboratories
5.3.3. Others
5.4. Market Analysis, Insights and Forecast – By Region
5.4.1. North America
5.4.2. Europe
5.4.3. Asia Pacific
5.4.4. Latin America
5.4.5. Middle East & Africa
6. North America Digital Pathology Market Analysis, Insights and Forecast, 2019-2032
6.1. Market Analysis, Insights and Forecast – By Product
6.1.1. Hardware
6.1.1.1. Scanners
6.1.1.2. Tissue Microarrayer
6.1.1.3. Others
6.1.2. Software
6.1.2.1. Pathology Management
6.1.2.2. Digital Microscopy Viewers
6.1.2.3. Image Analyzers
6.1.2.4. Others
6.1.3. Storage Systems
6.2. Market Analysis, Insights and Forecast – By Application
6.2.1. Disease Diagnosis
6.2.2. Drug Discovery
6.2.3. Others
6.3. Market Analysis, Insights and Forecast – By End User
6.3.1. Hospitals & Clinics
6.3.2. Clinical Laboratories
6.3.3. Others
6.4. Market Analysis, Insights and Forecast – By Country
6.4.1. U.S.
6.4.2. Canada
7. Europe Digital Pathology Market Analysis, Insights and Forecast, 2019-2032
7.1. Market Analysis, Insights and Forecast – By Product
7.1.1. Hardware
7.1.1.1. Scanners
7.1.1.2. Tissue Microarrayer
7.1.1.3. Others
7.1.2. Software
7.1.2.1. Pathology Management
7.1.2.2. Digital Microscopy Viewers
7.1.2.3. Image Analyzers
7.1.2.4. Others
7.1.3. Storage Systems
7.2. Market Analysis, Insights and Forecast – By Application
7.2.1. Disease Diagnosis
7.2.2. Drug Discovery
7.2.3. Others
7.3. Market Analysis, Insights and Forecast – By End User
7.3.1. Hospitals & Clinics
7.3.2. Clinical Laboratories
7.3.3. Others
7.4. Market Analysis, Insights and Forecast – By Country/ Sub-region
7.4.1. U.K.
7.4.2. Germany
7.4.3. France
7.4.4. Spain
7.4.5. Italy
7.4.6. Scandinavia
7.4.7. Rest of Europe
8. Asia Pacific Digital Pathology Market Analysis, Insights and Forecast, 2019-2032
8.1. Market Analysis, Insights and Forecast – By Product
8.1.1. Hardware
8.1.1.1. Scanners
8.1.1.2. Tissue Microarrayer
8.1.1.3. Others
8.1.2. Software
8.1.2.1. Pathology Management
8.1.2.2. Digital Microscopy Viewers
8.1.2.3. Image Analyzers
8.1.2.4. Others
8.1.3. Storage Systems
8.2. Market Analysis, Insights and Forecast – By Application
8.2.1. Disease Diagnosis
8.2.2. Drug Discovery
8.2.3. Others
8.3. Market Analysis, Insights and Forecast – By End User
8.3.1. Hospitals & Clinics
8.3.2. Clinical Laboratories
8.3.3. Others
8.4. Market Analysis, Insights and Forecast – By Country/ Sub-region
8.4.1. Japan
8.4.2. China
8.4.3. India
8.4.4. Australia
8.4.5. Southeast Asia
8.4.6. Rest of Asia Pacific
9. Latin America Digital Pathology Market Analysis, Insights and Forecast, 2019-2032
9.1. Market Analysis, Insights and Forecast – By Product
9.1.1. Hardware
9.1.1.1. Scanners
9.1.1.2. Tissue Microarrayer
9.1.1.3. Others
9.1.2. Software
9.1.2.1. Pathology Management
9.1.2.2. Digital Microscopy Viewers
9.1.2.3. Image Analyzers
9.1.2.4. Others
9.1.3. Storage Systems
9.2. Market Analysis, Insights and Forecast – By Application
9.2.1. Disease Diagnosis
9.2.2. Drug Discovery
9.2.3. Others
9.3. Market Analysis, Insights and Forecast – By End User
9.3.1. Hospitals & Clinics
9.3.2. Clinical Laboratories
9.3.3. Others
9.4. Market Analysis, Insights and Forecast – By Country/ Sub-region
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
10. Middle East & Africa Digital Pathology Market Analysis, Insights and Forecast, 2019-2032
10.1. Market Analysis, Insights and Forecast – By Product
10.1.1. Hardware
10.1.1.1. Scanners
10.1.1.2. Tissue Microarrayer
10.1.1.3. Others
10.1.2. Software
10.1.2.1. Pathology Management
10.1.2.2. Digital Microscopy Viewers
10.1.2.3. Image Analyzers
10.1.2.4. Others
10.1.3. Storage Systems
10.2. Market Analysis, Insights and Forecast – By Application
10.2.1. Disease Diagnosis
10.2.2. Drug Discovery
10.2.3. Others
10.3. Market Analysis, Insights and Forecast – By End User
10.3.1. Hospitals & Clinics
10.3.2. Clinical Laboratories
10.3.3. Others
10.4. Market Analysis, Insights and Forecast – By Country/ Sub-region
10.4.1. GCC Countries
10.4.2. South Africa
10.4.3. Rest of Middle East & Africa
11. Competitive Analysis
11.1. Global Market Share Analysis (2023)
11.2. Company Profiles
11.2.1. Leica Biosystems Nussloch GmbH
11.2.1.1. Overview
11.2.1.2. Products
11.2.1.3. SWOT analysis
11.2.1.4. Recent developments
11.2.1.5. strategies
11.2.1.6. financials (based on availability)
11.2.2. Thermo Fisher Scientific Inc.
11.2.2.1. Overview
11.2.2.2. Products
11.2.2.3. SWOT analysis
11.2.2.4. Recent developments
11.2.2.5. strategies
11.2.2.6. financials (based on availability)
11.2.3. F. Hoffmann-La Roche Ltd
11.2.3.1. Overview
11.2.3.2. Products
11.2.3.3. SWOT analysis
11.2.3.4. Recent developments
11.2.3.5. strategies
11.2.3.6. financials (based on availability)
11.2.4. Hamamatsu Photonics K.K.
11.2.4.1. Overview
11.2.4.2. Products
11.2.4.3. SWOT analysis
11.2.4.4. Recent developments
11.2.4.5. strategies
11.2.4.6. financials (based on availability)
11.2.5. Akoya Biosciences, Inc.
11.2.5.1. Overview
11.2.5.2. Products
11.2.5.3. SWOT analysis
11.2.5.4. Recent developments
11.2.5.5. strategies
11.2.5.6. financials (based on availability)
11.2.6. 3DHISTECH Ltd.
11.2.6.1. Overview
11.2.6.2. Products
11.2.6.3. SWOT analysis
11.2.6.4. Recent developments
11.2.6.5. strategies
11.2.6.6. financials (based on availability)
11.2.7. Koninklijke Philips N.V.
11.2.7.1. Overview
11.2.7.2. Products
11.2.7.3. SWOT analysis
11.2.7.4. Recent developments
11.2.7.5. strategies
11.2.7.6. financials (based on availability)
11.2.8. Apollo Enterprise Imaging Corp
11.2.8.1. Overview
11.2.8.2. Products
11.2.8.3. SWOT analysis
11.2.8.4. Recent developments
11.2.8.5. strategies
11.2.8.6. financials (based on availability)
11.2.9. Sectra AB
11.2.9.1. Overview
11.2.9.2. Products
11.2.9.3. SWOT analysis
11.2.9.4. Recent developments
11.2.9.5. strategies
11.2.9.6. financials (based on availability)
11.2.10. Huron Technologies International Inc.
11.2.10.1. Overview
11.2.10.2. Products
11.2.10.3. SWOT analysis
11.2.10.4. Recent developments
11.2.10.5. strategies
11.2.10.6. financials (based on availability)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings